Meet Ally, Clearity’s youngest supporter!
Hi, my name is Ally W.! I am 12 years old and I live in California. I’m in 7th grade and I am on the cheerleading team for my middle school. I enjoy baking, cheer, … Read more
Often I have lain under a sheet on a gurney in a hospital
The JAVELIN Ovarian 100 study has been terminated based on the finding, reported as part… Read more
By Rachel Moss
One in five ovarian cancer patients is too ill to treat by the time she receives her diagnosis, according to new data.
The charity Target Ovarian Cancer warned that delays in diagnosis are common and leave too … Read more
By Brielle Benyon
The Food and Drug Administration (FDA) approved Lynparza (olaparib) for the maintenance treatment of adults with deleterious or suspected deleterious germline or somatic BRCA-mutated advanced epithelial ovarian, fallopian tube or primary peritoneal cancer who are in a
… Read moreResearchers from the University of Texas MD Anderson Cancer Center have discovered that ovarian cancer cells spread, or metastasize, to new tissue after being caught in DNA “webs” extruded by immune cells. The study, which will be published in the … Read more
Hobbies, physical activity, and loved ones all help.
For some women, an ovarian cancer diagnosis comes after a lengthy, frustrating, stressful process, given that many don’t have observable symptoms until the cancer is in a more advanced … Read more
By Korin Miller
Navigating ovarian cancer treatment options can be overwhelming, but if you have this illness, it’s a part of the process.
There are five major forms of treatment for ovarian cancer. However, the type of ovarian cancer you … Read more
By Brooke Gant
One year ago, I was a healthy 32-year-old woman. Then, with a flurry of medical tests, I became an ovarian cancer patient.
I quickly learned that when you get hit by a difficult disease, you become vulnerable
By Regina Schaffer
Swedish women with polycystic ovary syndrome are 15% more likely to develop any cancer vs. women without the condition, with risk further elevated for cancers of the endometrium, ovary, pancreas and kidney, according to a research letter … Read more
Medical science has made tremendous advances in “personalized medicine” — drugs that fight cancer and other diseases by boosting the immune system or targeting specific genetic traits.
Former U.S. President Jimmy Carter benefited from one of these
… Read moreBy
Researchers have discovered a curious difference between the DNA from cancer cells and that from healthy cells, and this finding could lead to a new blood test for cancer.
The difference? Cancer DNA has a … Read more
By Katie Kosko
Whether it’s the person who receives a cancer diagnosis or family members who will watch their loved one go through it all,
… Read moreBy Selina McKee
A late-stage study testing Merck KGaA and Pfizer’s PD-L1 antibody Bavencio has failed to meet its primary endpoints in patients with certain forms of ovarian cancer.
The drug was being tested as monotherapy and in combination with … Read more
The Clearity Foundation has joined #GivingTuesday, a global day of giving that harnesses the collective power of individuals, communities and organizations to encourage philanthropy and to celebrate generosity worldwide.
Celebrated on the Tuesday following Thanksgiving, and the widely recognized shopping … Read more
Starting
January 1, 2025,
Clearity is joining
Ovarian Cancer
Research Alliance
(OCRA) and this website
will be redirected to
www.ocrahope.org
OCRA and Clearity are committed to serving the ovarian cancer community and providing the education, information, and support people need.
